Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient.

Hill, Joshua A; Ujjani, Chaitra S; Greninger, Alexander L; Shadman, Mazyar; Gopal, Ajay K

Hill, Joshua A; Ujjani, Chaitra S; Greninger, Alexander L; Shadman, Mazyar; Gopal, Ajay K.

Hill JA; Fred Hutchinson Cancer Research Center, Seattle, WA, USA; University of Washington, Seattle, WA, USA; Seattle Cancer Care Alliance, Seattle, WA, USA. Electronic address: jahill3@fredhutch.org.
Ujjani CS; Fred Hutchinson Cancer Research Center, Seattle, WA, USA; University of Washington, Seattle, WA, USA; Seattle Cancer Care Alliance, Seattle, WA, USA.
Greninger AL; Fred Hutchinson Cancer Research Center, Seattle, WA, USA; University of Washington, Seattle, WA, USA.
Shadman M; Fred Hutchinson Cancer Research Center, Seattle, WA, USA; University of Washington, Seattle, WA, USA; Seattle Cancer Care Alliance, Seattle, WA, USA.
Gopal AK; Fred Hutchinson Cancer Research Center, Seattle, WA, USA; University of Washington, Seattle, WA, USA; Seattle Cancer Care Alliance, Seattle, WA, USA.

Cancer Cell ; 39(8): 1037-1038, 2021 08 09.

Article in English | MEDLINE | ID: covidwho-1283966

Subject(s)

COVID-19; Lymphoma; COVID-19 Vaccines; Humans; SARS-CoV-2; Vaccination

Keywords

COVID-19; SARS-CoV-2; booster; hematologic malignancy; vaccine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Lymphoma Topics: Vaccines Limits: Humans Language: English Journal: Cancer Cell Journal subject: Neoplasms Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google